BRIEF-Agios Pharmaceuticals Says FDA Has Not Issued Decision On Agios' sNDA for Mitapivat Dec 8 (Reuters) - Agios Pharmaceuticals Inc AGIO.O:
AGIOS PROVIDES UPDATE ON U.S. SNDA FOR MITAPIVAT IN THALASSEMIA
AGIOS PHARMACEUTICALS INC - FDA HAS NOT ISSUED DECISION ON AGIOS' SNDA FOR MITAPIVAT
AGIOS PHARMACEUTICALS INC - COLLABORATING WITH FDA ON LABELING AND REMS MATERIALS FOR FOR MITAPIVAT
AGIOS PHARMACEUTICALS INC - FDA HAS NOT REQUESTED NEW EFFICACY OR SAFETY DATA
AGIOS PHARMACEUTICALS INC - FDA HAS NOT PROVIDED TIMELINE FOR REGULATORY DECISION
Source text: ID:nGNX5KLcnS
Further company coverage: AGIO.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments